EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study

Kurt Sartorius iD, Benn Sartorius, Cheryl Winkler, Anil Chuturgoon iD, Tsai-Wei Shen, Yongmei Zhao iD, Ping An iD

International Journal of Molecular Sciences · 12.01.2024 · 25 (2) · 975

DOI: 10.3390/ijms25020975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.01.2024. Verfasst von Kurt Sartorius und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Commerce, Law and Management, University of the Witwatersrand, Johannesburg 2001, South Africa. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CCR NIH HHS, NCI NIH HHS, Frederick National Laboratory for Cancer Research, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence and mortality of hepatocellular carcinoma (HCC) in Sub-Saharan Africa is projected to increase sharply by 2040 against a backdrop of limited diagnostic and therapeutic options. Two large South African-based case control studies have developed a serum-based miRNome for Hepatitis B-associated hepatocellular carcinoma (HBV-HCC), as well as identifying their gene targets and pathways. Using a combination of RNA sequencing, differential analysis and filters including a unique molecular index count (UMI) ≥ 10 and log fold change (LFC) range > 2:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis BMicroRNAsHumansSouth Africa

Stichwörter der Autor:innen

dysregulatedgene targetshepatitis B-associated carcinoma (HBV-HCC)microRNA (miRNA)modulatepathways

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Faculty of Commerce, Law and Management, University of the Witwatersrand, Johannesburg 2001, South Africa.
  • School of Laboratory Medicine and Molecular Sciences, University of Kwazulu-Natal, Durban 4041, South Africa.
  • Africa Hepatopancreatobiliary Cancer Consortium (AHPBCC), Mayo Clinic, Jacksonville, FL 32224, USA.
  • School of Public Health, University of Queensland, Brisbane, QLD 4102, Australia.
  • Centre for Cancer Research, Basic Research Laboratory, National Cancer Institute, Frederick Natifol Laboratory for Cancer Research, National Institute of Health, Frederick, MD 21701, USA.
  • CCR-SF Bioinformatics Group, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.

ORCID-Profile: Kurt Sartorius, Anil Chuturgoon, Yongmei Zhao, Ping An

Förderung

  • CCR NIH HHS
  • NCI NIH HHS
  • Frederick National Laboratory for Cancer Research, National Institutes of Health
  • Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research

Zitieren

APA

Sartorius, K., Sartorius, B., Winkler, C., Chuturgoon, A., Shen, T. W., Zhao, Y., & An, P. (2024). Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. International Journal of Molecular Sciences, 25(2), 975. https://doi.org/10.3390/ijms25020975

Vancouver

Sartorius K, Sartorius B, Winkler C, Chuturgoon A, Shen TW, Zhao Y, et al. Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. International Journal of Molecular Sciences. 2024;25(2):975. doi:10.3390/ijms25020975

BibTeX
@article{Sartorius2024,
  author = {Sartorius, Kurt and Sartorius, Benn and Winkler, Cheryl and Chuturgoon, Anil and Shen, Tsai-Wei and Zhao, Yongmei and An, Ping},
  title = {Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {2},
  pages = {975},
  doi = {10.3390/ijms25020975}
}
Kostenlos starten →